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Introduction
Pathologists have known for centuries that calcific deposits formed
in vascular tissues such as the aortic valve. Calcific deposits are hard
like bone and have often been described as such. In his ‘History of
Animals’, Aristotle remarked that often in oxen and particularly in
horse, the heart ‘has a bone inside it’.1 And in 1646, the French pro-
fessor of medicine Lazare Rivie´re described his post-mortem exam-
ination of a patient’s diseased aortic valve by remarking that it
resembled ‘a cluster of hazelnuts’.2 Today, aortic valve calcification
remains the most common cause of valve stenosis3,4 and is present
in some 26% of the population over the age of 65, and as many as
half of those over 85.5
Well into the 20th century, the formation of calcific lesions was
believed to be a normal, passive process associated with aging. In the
early 1990s, however, this attitude began to change when Bostro¨m
et al. identified bone morphogenetic protein-2a in calcified human
carotid arteries.6 Later, in addition to descriptions of standard ‘dys-
trophic calcification’, histological studies identified endochondral
bone formation in heavily calcified aortic valves7 and gene expres-
sion analyses demonstrated up-regulation of several bone-specific
genes.8 The biological case for bone formation in the vascular sys-
tem had been established, but how closely do calcific lesions resem-
ble bone as a material?
To understand bone, biomineralization researchers have long uti-
lized non-quantitative physical science techniques, including analytic-
al electron microscopy, to examine tissues ex vivo. Such analyses can
sometimes reveal more than standard histological stains that often
only detect the presence of calcium and/or phosphate. In particular,
standard histology does not definitively identify the specific type of
mineral present, as calcium phosphate can exist in .10 different
phases.9 The mollusc-smashing club that forms part of the exoskel-
eton of the variegated peacock mantis shrimp, for example, is partial-
ly formed of calcium phosphate,10 but fundamentally differs from
bone. By applying such characterization techniques to bone, we
know a great deal about its structure, composition, and mechanism
of formation. However, only recently have similar techniques been
applied to calcific lesions on the aortic valve. Here, we examine
this new evidence and compare it with similar studies conducted
on bone. These analyses lead us to believe that ubiquitous features
of calcific lesions cannot be explained either by classic descriptions
of dystrophic calcification or simply by ectopic bone formation. Con-
sequently, we advocate complementing current biologically focussed
research endeavours with interdisciplinary approaches to help disen-
tangle the interwoven biological and physicochemical processes that
drive aortic valve calcification with the aim of eventually developing
strategies to eliminate and/or prevent it.
Close to the bone: the structure
and composition of bone tissue
Because of its inorganic nature and function as a structural material
in the body, biologists and clinicians are not the only scientists who
study bone. Quite uniquely, it has also received significant attention
from the physical sciences communities. Chemists and engineers
have long studied bone samples ex vivo using electron microscopy
(nano-meter resolution imaging), energy dispersive X-ray spectros-
copy (elemental analysis), and selected area electron diffraction
(SAED, crystallographic structure) to precisely describe its hierarch-
ical structure and composition (Figure. 1). As a result, the basic struc-
ture of bone, whether it be lamellar or woven, mature or immature,
is well-established. In short, bone is composed of apatite crystals,
which closely associate with collagen fibres11 (Figure. 1A–C ), its
elemental composition is predominantly calcium, phosphorus, car-
bon and oxygen (Figure. 1E), and its mineral is poorly crystalline
(a measure of how regularly atoms align, Figure. 1D). Analyses of
bones from different species show that bone has a similar structure,
composition, and crystallinity across different sites in the body, and
more widely, that it is comparable in nearly all vertebrates that have
thus far been studied.12
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Heart of stone: the structure and
composition of aortic valve calcific
lesions
As the structure and composition of bone has been well described,
what then do the same techniques reveal about calcific lesions on
the aortic valve? There are numerous electron micrographs of hu-
man calcific lesions available in the literature13 – 20 and we exam-
ined14 .30 recovered human aortic valves ex vivo using this
non-quantitative technique. These images reveal that the inorganic
component of calcific lesions takes one of three structures
(Figure. 2A–C ). The most common mineralized structure are spher-
ical particles with sizes ranging from 100 nm to 5 mm (Figure. 2A).
These ‘billiard ball-like’ particles have been observed in diseased
samples, independent of disease severity. They are composed of cal-
cium, phosphorus, oxygen, and magnesium (Figure. 2H), and their
inner structure is formed from concentric layers of mineral distrib-
uted radially from the centre (Figure 2D).14 Although visible in SEM
images published over the last 30 years,16,21 their presence was dis-
missed until recently, likely because standard TEM sample prepar-
ation fractures the spherical particles and histology techniques can
miss them, as they are transparent like a quartz crystal.
‘Matrix vesicles’, membrane-bound spherical structures that con-
tain clusters of needle-like mineral, play an important role in medi-
ating bone formation. The dense, spherical mineral particles in aortic
valve calcifications, however, fundamentally differ from matrix vesi-
cles in composition and structure.22 – 25 Spherical particles tend to
be larger than matrix vesicles, which are only 100 nm in diam-
eter,22,26 and are solid completely through. In contrast, matrix vesi-
cles mineralize along their membranes and often have hollow cores.
Moreover, while matrix vesicles contain amorphous mineral,22 the
atoms that comprise spherical particles are arranged in a highly
ordered fashion, like a single crystal14 (Figure 2F). In fact, the spots
(or reflections) in their SAED patterns demonstrate that their
mineral is different from any other material found in the body.
They are unquestionably far more crystalline than bone.
Figure 1 The nano-structure and composition of bone. (A and B) Representative density-dependent colour scanning electron micrographs of
the surface of bone tissue from a human femoral head showing a homogenous density distribution of mineralized collagen fibres. The orange
colour identifies the mineral, while green highlights the organic components of the tissue. Scale bar in (A): 10 mm and in (B) 1 mm. (C) Transmission
electron microscopy image of bone. Green arrows and box indicate banded collagen fibres and black arrows highlight dark plate-like crystals.
Notice how the dark crystals directly interact with the light collagen fibrils. Scale bar ¼ 0.2 mm. (D) Selected area electron diffraction pattern
of bone showing broad diffraction rings/halos (white arrows) indicative of disorder in the material’s atomic structure. The central bright spot re-
presents the source electron beam (black arrow). The broad diffraction rings/halos are created by reflections of disordered atoms within the
material. (E) Energy dispersion X-ray spectroscopy elemental analysis of bone highlighting its composition: calcium, phosphorus, carbon, and
oxygen.
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The other two structures commonly found in calcific lesions are
calcified fibres and compact calcification (Figure 2B and C ).14 Most
calcific lesions with these structures are likely formed by dystrophic
mineralization, although 13% are reportedly true bone and possess
features of mature lamellar bone, including mineral that templates
on a collagen matrix.7 Most calcific lesions lack the nano-level organ-
ization typical of bone (Figure 2E), and although they are composed
of calcium, phosphorus and oxygen, they do not contain detectable
levels of magnesium (Figure 2I) and their mineral is poorly crystal-
line14 (Figure 2G). Interestingly, most mineralized structures in calcif-
ic lesions do not interact with collagen fibres. Instead, the mineral
structures and organic components remain as isolated elements,
each maintaining their own structural identity (Figure 3).
A change of heart: do mineralized
particles play a role in aortic valve
calcification?
As conventional and emerging biological techniques are already pro-
viding exciting new insights into its pathogenesis, what additionally
can we learn about aortic valve calcification from studying how
bone forms? First, observations of ubiquitous spherical particles in
diseased valves examined ex vivo suggest that calcific lesion forma-
tion does not follow a similar pattern to bone mineralization. One
of the hallmarks of bone formation is that mineral crystals template
on a collagen matrix.11,27– 28 This is not the case in most calcific le-
sions in which the organic matrix does not associate with the min-
eral. Moreover, on the aortic valve, dense spherical particles are the
first mineralized structure observed, and they are present even
prior to the formation of calcific lesions.14 This observation offers
the possibility that particles may play a role in mediating further min-
eralization. Indeed, their presence poses a number of questions:
What is the role (if any) of these particles in calcification? Could
they be initiators of calcification or a consequence?
Analyses of calcific lesions with physical science techniques also
provide complementary evidence to that gained from traditional
biological techniques. For example, it has confirmed histological
studies that show that the composition and structure of most calcific
lesions are not bone like. True bone formation reportedly only oc-
curs in a small fraction of calcific lesions, and therefore may be a con-
sequence of calcification rather than a cause.29 The biomaterials
community has long known that implanting some forms of calcium
phosphate intramuscularly can prompt bone formation.30,31
Figure 2 The nano-structure and composition of human aortic valve calcification. Representative density-dependent colour scanning electron
micrographs of (A) calcified particles (arrow, scale bar ¼ 1 mm), (B) calcified fibres (arrow, scale bar ¼ 10 mm), and (C) compact calcification
(white arrow) with a calcified particle (black arrow) in human aortic valve tissue (scale bar ¼ 1 mm). Calcified areas appear orange, while the
unmineralized extracellular matrix is shown in green. (D) Transmission electron microscopy image of a section through a calcified spherical par-
ticle. Notice that the particle is composed of a dense material all the way through. Scale bar ¼ 0.2 mm. (E) Transmission electron microscopy
image of compact calcification showing a trapped sphere (yellow arrow), compact amorphous calcium phosphate (white arrow), and collagen
fibrils (black arrow). Notice how each component maintains its own structural identity. Scale bar ¼ 0.2 mm. (F) Selected area electron diffraction
of a calcified spherical particle. The diffraction pattern shows regularly spaced bright spots or reflections (white arrow) of the diffracted source
electron beam (black arrow). Regularly spaced reflections are created by materials that have highly ordered atomic structure. (G) Selected
area electron diffraction of compact calcification with a typical amorphous pattern, marked by broad diffraction rings/halos (white arrow) which
reflect from the source electron beam (black arrow). Broad diffraction rings/halos are generated by the irregular arrangement of atoms within a
material’s structure. (H) Energy dispersion X-ray spectroscopy of a calcified particle showing that it is composed of calcium, phosphorus, and
magnesium. (I) Energy dispersion X-ray spectroscopy of compact calcification presenting calcium and phosphorus.
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Moreover, the presence of hydroxyapatite nano-crystals has been
shown to upregulate osteogenic gene expression in vascular
smooth muscle cells.32 If a similar mechanism manifested in the vas-
cular system, the localization of calcium phosphate to valves could
trigger cell transdifferentiation, bone-specific protein formation and
gene expression, and eventually actual bone formation. Although a
mechanism by which this process might proceed remains unclear,
interstitial valve cells have transdifferentiation and mineralization
potential.33 Moreover, cell biologists have recently recognized
that the stiffness of the substrate on which cells attach can affect
their phenotype.34,35 Stiff surfaces that mimic the stiffness of the de-
veloping osteon, for example, direct mesenchymal stem cells to dif-
ferentiate to osteoblasts. If the same were true in the aortic valve,
stiff calcium phosphate might drive the transdifferentiation of local
Figure 3 The hierarchical and ordered structure of bone compared with inhomogenous aortic valve calcification. Diagram shows the structure
of each tissue at the macroscopic, micron (visible by scanning electron microscopy), and nano (visible by transmission electron microscopy)
scales. I. Macroscopic schematic bone. II. Collagen fibrils covered by calcium phosphate mineral. III. Collagen fibrils associated with calcium phos-
phate mineral crystals at the nano-scale. IV. Macroscopic schematic of cardiac tissue. V. Micron-level structures observed in aortic valve calcific
lesions. VI. Organization of calcific lesions which contain fibrous structures, calcified particles, and compact calcification. Table summarizes the
characteristics of bone as compared with aortic valve calcific lesions.
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cells or prompt circulating cells to adhere and adopt an osteoblastic
phenotype.
The best of both worlds: the
potential of an interdisciplinary
approach
As vascular calcification appears to be more complex than either
simple dystrophic mineral formation or a cell-mediated process of
bone formation ‘in the wrong place’,36 how then can the field
move forward to develop treatments for calcific diseases? The
methods now available include biological, biochemical, materials,
and clinical techniques. Combining methods and taking an interdis-
ciplinary approach has already yielded promising new avenues of re-
search, as detailed here, and their continued use could be similarly
efficacious. For example, optical and fluorescence microscopy are
powerful techniques for visualizing cells and identifying labelled pro-
teins. However, they can only reveal insights at the micro-scale be-
cause of the inherent limitations of the wavelength of light. On the
other hand, analytical electron microscopy is non-quantitative and
often cannot provide biological information about cells and pro-
teins, but it can produce ultra-high-resolution images of ex vivo sam-
ples and provide clear information about tissue morphology,
mineral crystallinity, and elemental composition. Combining the
two is possible and the techniques are not inaccessible to standard
laboratories. Moreover, the two methods can be used sequentially
on the same sample.37 To study aortic valve calcification, sections of
recovered valves labelled for specific proteins could be correlated
with electron micrographs highlighting the location, size and com-
position of calcified areas. Elemental analysis applied directly to cells
and their labelled compartments might also identify if and how spe-
cific cellular organelles might contribute to mineral nucleation and/
or subsequent propagation.22
Although an expectation that advances will come from applying
physical science techniques to ex vivo aortic valve calcific lesions
might seem like wishful thinking, methods borrowed from physics
and chemistry are pervasive in clinical medicine. Ultrasound was first
pioneered as a geological technique before it found a plethora of
uses in medical imaging, and chemists utilized nuclear magnetic res-
onance (NMR) to verify the molecular structure of chemicals before
the technique was applied in diagnostic radiology. Even electron mi-
croscopy techniques have been used for years to diagnose chronic
renal allograft rejection and various viral infections. Indeed, in some
circumstances electron microscopy remains the best diagnostic
method available.38– 45
Conclusions
Interdisciplinary research approaches have revealed new insights
into the pathogenesis of aortic valve calcification. In particular,
they have led to the discovery that calcific lesions contain unique,
highly crystalline spherical particles. Applying such techniques can
complement existing approaches, providing additional insights into
aortic valve calcification, and perhaps also pathways for clinical
treatments. For example, although our understanding of spherical
particles in the vascular system is limited, their highly crystalline
nature suggests that they would be quite difficult to dissolve. A con-
sequence of this might be that research efforts that aim to prevent
calcification or limit its progression, rather than trying to remove
them, may be more clinically effective. Such new ways of looking
at long-standing research problems may foster advances in cardio-
vascular and biomedical research.
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